NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing delivery of nutritive elements and medicants through licensing arrangements.
The last earnings update was 24 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
NanoSphere Health Sciences. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
NanoSphere Health Sciences's
is considered below, and whether this is a fair price.
Price based on past earnings
NanoSphere Health Sciences's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NanoSphere Health Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
NanoSphere Health Sciences
expected to grow at an
Unable to compare NanoSphere Health Sciences's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare NanoSphere Health Sciences's earnings growth to the Canada market average as no estimate data is available.
Unable to compare NanoSphere Health Sciences's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if NanoSphere Health Sciences is high growth as no earnings estimate data is available.
Unable to determine if NanoSphere Health Sciences is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
NanoSphere Health Sciences's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
NanoSphere Health Sciences
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
NanoSphere Health Sciences's finances.
The net worth of a company is the difference between its assets and liabilities.
NanoSphere Health Sciences's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
NanoSphere Health Sciences has no long term commitments.
This treemap shows a more detailed breakdown of
NanoSphere Health Sciences's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
NanoSphere Health Sciences has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. Mark Percival has been the Chief Executive Officer at NanoSphere Health Sciences Inc. since June 2019. Dr. Percival has extensive experience in the healthcare field across two continents and has led important innovations for more than three decades. Dr. Percival has become an inspirational leader and a very special resource in healthcare innovation and value-based care.
Insufficient data for Mark to compare compensation growth.
Insufficient data for Mark to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure
Average tenure and age of the
NanoSphere Health Sciences
management team in years:
The average tenure for the NanoSphere Health Sciences management team is less than 2 years, this suggests a new team.
Chief Financial Officer
Director & COO
Chief Executive Officer
Co-Founder & Chief Medical Director
Executive Vice President
Chief Marketing Officer of NanoSphere Health Sciences
Board of Directors Tenure
Average tenure of the
NanoSphere Health Sciences
board of directors in years:
The average tenure for the NanoSphere Health Sciences board of directors is less than 3 years, this suggests a new board.
Such Is Life: How NanoSphere Health Sciences (CNSX:NSHS) Shareholders Saw Their Shares Drop 55%
View our latest analysis for NanoSphere Health Sciences NanoSphere Health Sciences recorded just US$302,941 in revenue over the last twelve months, which isn't really enough for us to consider it to have a proven product. … It seems likely some shareholders believe that NanoSphere Health Sciences will significantly advance the business plan before too long. … If you would like to research NanoSphere Health Sciences in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing delivery of nutritive elements and medicants through licensing arrangements. The company develops NanoSphere drug delivery system, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.